Technology Transfer: door opener for collaboration opportunities 

With targeted technology transfer, PSI pursues the goal of strengthening the competitiveness and innovative strength of Swiss companies in particular through an active exchange between research and industry. New knowledge and findings from research should lead to new ideas, problem solutions and marketable innovations.

The technology transfer team at PSI represents the interface between research and third parties and is a door opener for collaborations with industry, SMEs or academic partners.


Expertise and Services

The Paul Scherrer Institute (PSI) provides a comprehensive range of Research- and Development-Services. Our experts knowledge as well as the qualified laboratories of PSI are appreciated and frequently used by industry.
20120328 Techtransfer 0045.jpg

Technology transfer

PSI strives to make new findings from research accessible to the industry to strengthen the competitiveness of Swiss industrial enterprises. As a result, firms can launch innovations on the market, secure existing jobs and even create new ones.

ANAXAM: Technologytransfer Center for Advanced Manufacturing

The newly founded technology transfer centre ANAXAM forms a bridge between research and industry. Find out here how you can use the new possibilities to optimize products and processes for your company.

GratXray klein.jpg

Spin-off companies

The activities in research and technology at PSI open up a great variety of opportunities for commercial exploitation.
If these technologies or services apply to an entrepreneurial scientist the foundation of a start-up company is a potential next step. PSI fosters and encourages the foundation of spin-off companies through advice and coaching from the transfer centre and with various different support tools.
web PARK innovAARE.jpg

Park innovaare: innovation park @ PSI

Park innovaare is a unique innovation center situated in close proximity to the Paul Scherrer Institute (PSI) and its state-of-the-art accelerator-based large research facilities. Here, driven by the PSI’s expertise, innovations in the fields of accelerator technology, advanced materials and processes, humans and health, and energy are transformed into marketable products and solutions.

Together with companies

The expertise and infrastructure of the Paul Scherrer Institute (PSI) are open to companies. Many partners have profited from the collaboration with PSI, as shown by the following references.

16 May 2023

Promising collaboration with ITM in the field of cancer therapy

PSI and ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, have entered into a collaboration for the joint development of the production of a novel therapeutic radionuclide, terbium-161. In this collaboration, PSI and ITM will combine their respective technologies and expertise in the production of terbium-161, including clinical and commercial use in targeted radionuclide therapy for the treatment of cancer. The goal is to be able to offer cancer patients new and better treatment options.

Terbium-161 has been identified as a very promising therapeutic isotope for targeted radionuclide therapy in cancer due to its excellent physicochemical properties: The convincing therapeutic capabilities of terbium-161 have been demonstrated in various preclinical studies at PSI. The collaboration with ITM - a pioneer and major player in the field of radiopharmaceutical applications - aims to combine PSI's long-standing research with ITM's extensive knowledge to drive further innovation in radionuclide therapy.

With this collaboration, ITM expands its research and production portfolio alongside Lutetium-177 and Actinium-225, which are currently the most widely used medical radioisotopes for targeted radionuclide therapy and which ITM supplies to hospitals and pharmaceutical partners worldwide.

Read more



Technology Transfer
John Millard

+41 56 310 41 83